Which has better earnings and valuation, MDAI or PDEX?

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $19.65M 2.62 -$7.57M -$0.35 N/A Pro-Dex $77.55M 2.59 $13.66M $4.13 15.21

Is MDAI or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to Spectral AI's net margin of -69.27%. Pro-Dex's return on equity of 25.13% beat Spectral AI's return on equity. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Pro-Dex 17.62% 25.13% 16.02%

Does the media favor MDAI or PDEX?

In the previous week, Pro-Dex had 5 more articles in the media than Spectral AI. MarketBeat recorded 8 mentions for Pro-Dex and 3 mentions for Spectral AI. Spectral AI's average media sentiment score of 0.82 beat Pro-Dex's score of 0.75 indicating that Spectral AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is MDAI or CNXU more profitable?

Conexeu Sciences has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Conexeu Sciences N/A N/A N/A

Do analysts rate MDAI or ZJYL?

Spectral AI currently has a consensus target price of $4.00, suggesting a potential upside of 150.00%. Given Spectral AI's stronger consensus rating and higher probable upside, equities research analysts clearly believe Spectral AI is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, MDAI or ZJYL?

Jin Medical International has higher revenue and earnings than Spectral AI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $19.65M 2.62 -$7.57M -$0.35 N/A Jin Medical International $20.69M 7.85 $1.19M N/A N/A

Is MDAI or ZJYL more profitable?

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Jin Medical International N/A N/A N/A

Does the media refer more to MDAI or ZJYL?

In the previous week, Spectral AI and Spectral AI both had 3 articles in the media. Jin Medical International's average media sentiment score of 1.10 beat Spectral AI's score of 0.82 indicating that Jin Medical International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Jin Medical International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is FOCL or MDAI more profitable?

FocalTherics has a net margin of -56.26% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets FocalTherics -56.26% -248.00% -44.69% Spectral AI -69.27% N/A -78.56%

Does the media favor FOCL or MDAI?

In the previous week, Spectral AI had 1 more articles in the media than FocalTherics. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for FocalTherics. FocalTherics' average media sentiment score of 1.45 beat Spectral AI's score of 0.82 indicating that FocalTherics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FocalTherics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Spectral AI 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MDAI or KRMD?

In the previous week, KORU Medical Systems had 2 more articles in the media than Spectral AI. MarketBeat recorded 5 mentions for KORU Medical Systems and 3 mentions for Spectral AI. KORU Medical Systems' average media sentiment score of 1.88 beat Spectral AI's score of 0.82 indicating that KORU Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KORU Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Spectral AI (MDAI) Competitors

$1.60 +0.04 (+2.56%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$1.60 -0.01 (-0.31%)

As of 09/11/2026 07:30 PM Eastern

Compare

MDAI vs. PDEX, CNXU, ZJYL, FOCL, and KRMD

Should you buy Spectral AI stock or one of its competitors? Spectral AI's main competitors and comparable companies include Pro-Dex (PDEX), Conexeu Sciences (CNXU), Jin Medical International (ZJYL), FocalTherics (FOCL), and KORU Medical Systems (KRMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Spectral AI compare to Pro-Dex?

Spectral AI (NASDAQ:MDAI) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Comparatively, 45.9% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Pro-Dex had 5 more articles in the media than Spectral AI. MarketBeat recorded 8 mentions for Pro-Dex and 3 mentions for Spectral AI. Spectral AI's average media sentiment score of 0.82 beat Pro-Dex's score of 0.75 indicating that Spectral AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pro-Dex has a net margin of 17.62% compared to Spectral AI's net margin of -69.27%. Pro-Dex's return on equity of 25.13% beat Spectral AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Pro-Dex	17.62%	25.13%	16.02%

Pro-Dex has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.62	-$7.57M	-$0.35	N/A
Pro-Dex	$77.55M	2.59	$13.66M	$4.13	15.21

Spectral AI has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

Spectral AI currently has a consensus price target of $4.00, suggesting a potential upside of 150.00%. Pro-Dex has a consensus price target of $74.00, suggesting a potential upside of 17.82%. Given Spectral AI's higher probable upside, research analysts plainly believe Spectral AI is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Pro-Dex beats Spectral AI on 10 of the 16 factors compared between the two stocks.

How does Spectral AI compare to Conexeu Sciences?

Spectral AI (NASDAQ:MDAI) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

67.1% of Spectral AI shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Conexeu Sciences has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Conexeu Sciences	N/A	N/A	N/A

Conexeu Sciences has lower revenue, but higher earnings than Spectral AI. Conexeu Sciences is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.62	-$7.57M	-$0.35	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A

In the previous week, Spectral AI had 1 more articles in the media than Conexeu Sciences. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for Conexeu Sciences. Spectral AI's average media sentiment score of 0.82 beat Conexeu Sciences' score of 0.43 indicating that Spectral AI is being referred to more favorably in the media.

Company	Overall Sentiment
Spectral AI	Positive
Conexeu Sciences	Neutral

Spectral AI currently has a consensus price target of $4.00, suggesting a potential upside of 150.00%. Conexeu Sciences has a consensus price target of $20.00, suggesting a potential upside of 348.43%. Given Conexeu Sciences' higher possible upside, analysts clearly believe Conexeu Sciences is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Spectral AI beats Conexeu Sciences on 8 of the 13 factors compared between the two stocks.

How does Spectral AI compare to Jin Medical International?

Spectral AI (NASDAQ:MDAI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

Spectral AI has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.31, suggesting that its share price is 631% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Jin Medical International	N/A	N/A	N/A

Jin Medical International has higher revenue and earnings than Spectral AI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.62	-$7.57M	-$0.35	N/A
Jin Medical International	$20.69M	7.85	$1.19M	N/A	N/A

67.1% of Spectral AI shares are held by institutional investors. 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Spectral AI currently has a consensus target price of $4.00, suggesting a potential upside of 150.00%. Given Spectral AI's stronger consensus rating and higher probable upside, equities research analysts clearly believe Spectral AI is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Spectral AI and Spectral AI both had 3 articles in the media. Jin Medical International's average media sentiment score of 1.10 beat Spectral AI's score of 0.82 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jin Medical International	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Jin Medical International beats Spectral AI on 7 of the 13 factors compared between the two stocks.

How does Spectral AI compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Spectral AI had 1 more articles in the media than FocalTherics. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for FocalTherics. FocalTherics' average media sentiment score of 1.45 beat Spectral AI's score of 0.82 indicating that FocalTherics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FocalTherics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spectral AI	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

FocalTherics has a beta of -0.07, indicating that its share price is 107% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

FocalTherics presently has a consensus price target of $7.75, indicating a potential upside of 89.02%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 150.00%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Spectral AI has lower revenue, but higher earnings than FocalTherics. Spectral AI is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.18	-$29.25M	-$1.03	N/A
Spectral AI	$19.65M	2.62	-$7.57M	-$0.35	N/A

FocalTherics has a net margin of -56.26% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Spectral AI	-69.27%	N/A	-78.56%

62.7% of FocalTherics shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 10.1% of FocalTherics shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Spectral AI beats FocalTherics on 10 of the 15 factors compared between the two stocks.

How does Spectral AI compare to KORU Medical Systems?

Spectral AI (NASDAQ:MDAI) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

KORU Medical Systems has higher revenue and earnings than Spectral AI. KORU Medical Systems is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.62	-$7.57M	-$0.35	N/A
KORU Medical Systems	$41.13M	3.53	-$2.64M	-$0.04	N/A

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 13.7% of Spectral AI shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Spectral AI has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

Spectral AI presently has a consensus price target of $4.00, indicating a potential upside of 150.00%. KORU Medical Systems has a consensus price target of $7.00, indicating a potential upside of 121.52%. Given Spectral AI's stronger consensus rating and higher possible upside, research analysts plainly believe Spectral AI is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has a net margin of -4.03% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

In the previous week, KORU Medical Systems had 2 more articles in the media than Spectral AI. MarketBeat recorded 5 mentions for KORU Medical Systems and 3 mentions for Spectral AI. KORU Medical Systems' average media sentiment score of 1.88 beat Spectral AI's score of 0.82 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

KORU Medical Systems beats Spectral AI on 10 of the 17 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDAI vs. The Competition

Export

Metric	Spectral AI	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$51.50M	$5.48B	$7.17B	$12.85B
Dividend Yield	N/A	1.79%	2.57%	11.71%
P/E Ratio	-4.57	25.09	274.94	25.33
Price / Sales	2.62	71.54	685.45	111.15
Price / Cash	N/A	32.57	76.65	51.52
Price / Book	-8.42	5.97	10.33	6.20
Net Income	-$7.57M	$150.75M	$3.50B	$358.50M
7 Day Performance	1.91%	-2.83%	-3.32%	-2.35%
1 Month Performance	1.91%	-3.09%	-0.41%	-2.77%
1 Year Performance	-17.53%	9.34%	19.21%	7.63%

Spectral AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDAI Spectral AI	1.9575 of 5 stars	$1.60 +2.6%	$4.00 +150.0%	-19.6%	$51.50M	$19.65M	N/A	83	News Coverage Analyst Upgrade
PDEX Pro-Dex	3.291 of 5 stars	$61.40 -1.1%	$70.00 +14.0%	+78.5%	$198.27M	$66.59M	16.96	140	News Coverage Positive News Analyst Forecast Insider Trade
CNXU Conexeu Sciences	2.7522 of 5 stars	$5.87 -18.2%	$20.00 +240.7%	N/A	$191.99M	N/A	N/A	4	Short Interest Increase
ZJYL Jin Medical International	1.2832 of 5 stars	$2.20 -5.2%	N/A	-84.6%	$181.96M	$20.69M	N/A	245	Positive News Short Interest Decrease
FOCL FocalTherics	4.2641 of 5 stars	$4.31 +0.9%	$7.75 +79.8%	N/A	$160.24M	$70.53M	N/A	230

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDAI) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Spectral AI (MDAI) Competitors

MDAI vs. PDEX, CNXU, ZJYL, FOCL, and KRMD

How does Spectral AI compare to Pro-Dex?

Summary

How does Spectral AI compare to Conexeu Sciences?

Summary

How does Spectral AI compare to Jin Medical International?

Summary

How does Spectral AI compare to FocalTherics?

Summary

How does Spectral AI compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Spectral AI (MDAI) Competitors

MDAI vs. PDEX, CNXU, ZJYL, FOCL, and KRMD

How does Spectral AI compare to Pro-Dex?

Do insiders & institutionals have more ownership in MDAI or PDEX?

Does the media favor MDAI or PDEX?

Is MDAI or PDEX more profitable?

Which has better earnings and valuation, MDAI or PDEX?

Which has more risk & volatility, MDAI or PDEX?

Do analysts rate MDAI or PDEX?

Summary

How does Spectral AI compare to Conexeu Sciences?

Do insiders and institutionals hold more shares of MDAI or CNXU?

Is MDAI or CNXU more profitable?

Which has preferable valuation and earnings, MDAI or CNXU?

Does the media refer more to MDAI or CNXU?

Do analysts recommend MDAI or CNXU?

Summary

How does Spectral AI compare to Jin Medical International?

Which has more risk & volatility, MDAI or ZJYL?

Is MDAI or ZJYL more profitable?

Which has preferable valuation and earnings, MDAI or ZJYL?

Do insiders & institutionals hold more shares of MDAI or ZJYL?

Do analysts rate MDAI or ZJYL?

Does the media refer more to MDAI or ZJYL?

Summary

How does Spectral AI compare to FocalTherics?

Does the media favor FOCL or MDAI?

Which has more risk & volatility, FOCL or MDAI?

Do analysts recommend FOCL or MDAI?

Which has better valuation and earnings, FOCL or MDAI?

Is FOCL or MDAI more profitable?

Do insiders & institutionals hold more shares of FOCL or MDAI?

Summary

How does Spectral AI compare to KORU Medical Systems?

Which has preferable earnings and valuation, MDAI or KRMD?

Do institutionals and insiders believe in MDAI or KRMD?

Which has more risk & volatility, MDAI or KRMD?

Do analysts prefer MDAI or KRMD?

Is MDAI or KRMD more profitable?

Does the media prefer MDAI or KRMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools